Mr. Shaun Flanagan:

When I say that, I assumed the Deputy was talking about a pan-approach. If it involves specific medicines, obviously, each of the countries will be engaging with its medical communities. In that way, they are linked if there is specific medication going through the process.

I was answering the question in the converse. I thought the Deputy was asking, under BeneluxA, is there an agreement around some sort of engagement between our professional bodies. There is not. It is a price and reimbursement assessment engagement.